335
Views
2
CrossRef citations to date
0
Altmetric
REVIEW

Urinary Antigen Testing for Respiratory Infections: Current Perspectives on Utility and Limitations

ORCID Icon, &
Pages 2219-2228 | Published online: 27 Apr 2022

References

  • Jain S, Self WH, Wunderink RG, et al. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med. 2015;373(5):415–427. doi:10.1056/NEJMoa1500245
  • Viasus D, Calatayud L, McBrown MV, Ardanuy C, Carratala J. Urinary antigen testing in community-acquired pneumonia in adults: an update. Expert Rev Anti Infect Ther. 2019;17(2):107–115. doi:10.1080/14787210.2019.1565994
  • Torres A, Cilloniz C, Niederman MS, et al. Pneumonia. Nat Rev Dis Primer. 2021;7(1):25. doi:10.1038/s41572-021-00259-0
  • Laijen W, Snijders D, Boersma WG. Pneumococcal urinary antigen test: diagnostic yield and impact on antibiotic treatment. Clin Respir J. 2017;11(6):999–1005.
  • van der Eerden MM, Vlaspolder F, de Graaff CS, Groot T, Jansen HM, Boersma WG. Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia. Eur J Clin Microbiol Infect Dis. 2005;24(4):241–249. doi:10.1007/s10096-005-1316-8
  • Waterer GW, Wunderink RG. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir Med. 2001;95(1):78–82. doi:10.1053/rmed.2000.0977
  • Chalasani NP, Valdecanas MAL, Gopal AK, McGowan JE, Jurado RL. Clinical Utility of Blood Cultures in Adult Patients with Community-Acquired Pneumonia Without Defined Underlying Risks. Chest. 1995;108(4):932–936. doi:10.1378/chest.108.4.932
  • Falguera M, Trujillano J, Caro S, et al. A Prediction Rule for Estimating the Risk of Bacteremia in Patients with Community‐Acquired Pneumonia. Clin Infect Dis. 2009;49(3):409–416. doi:10.1086/600291
  • Campbell SG, Marrie TJ, Anstey R, Dickinson G, Ackroyd-Stolarz S. The Contribution of Blood Cultures to the Clinical Management of Adult Patients Admitted to the Hospital With Community-Acquired Pneumonia. Chest. 2003;123(4):1142–1150. doi:10.1378/chest.123.4.1142
  • Corbo J, Friedman B, Bijur P, Gallagher EJ. Limited usefulness of initial blood cultures in community acquired pneumonia. Emerg Med J. 2004;4:446–448.
  • Campbell SG. Utility of blood cultures in the management of adults with community acquired pneumonia discharged from the emergency department. Emerg Med J. 2003;20(6):521–523. doi:10.1136/emj.20.6.521
  • Haessler S, Lindenauer PK, Zilberberg MD, et al. Blood Cultures Versus Respiratory Cultures: 2 Different Views of Pneumonia. Clin Infect Dis. 2020;71(7):1604–1612. doi:10.1093/cid/ciz1049
  • Benenson RS, Kepner AM, Pyle DN, Cavanaugh S. Selective Use of Blood Cultures in Emergency Department Pneumonia Patients. J Emerg Med. 2007;33(1):1–8. doi:10.1016/j.jemermed.2006.12.034
  • Hyams C, Williams OM, Williams P. Urinary antigen testing for pneumococcal pneumonia: is there evidence to make its use uncommon in clinical practice? ERJ Open Research. 2020;6(1):00223–2019.
  • Molinos L, Zalacain R, Menéndez R, et al. Sensitivity, specificity, and positivity predictors of the pneumococcal urinary antigen test in community-acquired pneumonia. Ann Am Thorac Soc. 2015;12(10):1482–1489.
  • Schimmel JJ, Haessler S, Imrey P, et al. Pneumococcal Urinary Antigen Testing in United States Hospitals: a Missed Opportunity for Antimicrobial Stewardship. Clin Infect Dis. 2020;71(6):1427–1434.
  • Ogawa H, Kitsios GD, Iwata M, Terasawa T. Sputum Gram Stain for Bacterial Pathogen Diagnosis in Community-acquired Pneumonia: a Systematic Review and Bayesian Meta-analysis of Diagnostic Accuracy and Yield. Clin Infect Dis off Publ Infect Dis Soc Am. 2020;71(3):499–513. doi:10.1093/cid/ciz876
  • Couturier MR, Graf EH, Griffin AT. Urine Antigen Tests for the Diagnosis of Respiratory Infections. Clin Lab Med. 2014;34(2):219–236. doi:10.1016/j.cll.2014.02.002
  • Song JY, Eun BW, Nahm MH. Diagnosis of Pneumococcal Pneumonia: current Pitfalls and the Way Forward. Infect Chemother. 2013;45(4):351. doi:10.3947/ic.2013.45.4.351
  • Marcos MA, Anta MT, Bellacasa JP, et al. Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults. Eur Respir J. 2003;21(2):209–214. doi:10.1183/09031936.03.00058802
  • Dochez AR, Avery OT. The elaboration of specific soluble substance by Pneumococcus during growth. J Exp Med. 1917;26(4):477–493.
  • Harris AM, Beekmann SE, Polgreen PM, Moore MR. Rapid urine antigen testing for Streptococcus pneumoniae in adults with community-acquired pneumonia: clinical use and barriers. Diagn Microbiol Infect Dis. 2014;79(4):454–457. doi:10.1016/j.diagmicrobio.2014.05.008
  • Athlin S, Iversen A, Özenci V. Comparison of the ImmuView and the BinaxNOW antigen tests in detection of Streptococcus pneumoniae and Legionella pneumophila in urine. Eur J Clin Microbiol Infect Dis. 2017;36(10):1933–1938. doi:10.1007/s10096-017-3016-6
  • Jorgensen CS, Uldum SA, Sorensen JF, Skovsted IC, Otte S, Elverdal PL. Evaluation of a new lateral flow test for detection of Streptococcus pneumoniae and Legionella pneumophila urinary antigen. J Microbiol Methods. 2015;116:33–36. doi:10.1016/j.mimet.2015.06.014
  • Athlin S, Altun O, Eriksen HB, Özenci V, Strålin K. The Uni-Gold<sup>TM{{sup}} Streptococcus pneumoniae urinary antigen test: an interassay comparison with the BinaxNOW® Streptococcus pneumoniae test on consecutive urine samples and evaluation on patients with bacteremia. Eur J Clin Microbiol Infect Dis. 2015;34(8):1583–1588. doi:10.1007/s10096-015-2390-1
  • Wong AYW, Johnsson ATA, Ininbergs K, Athlin S, Özenci V. Comparison of Four Streptococcus pneumoniae Urinary Antigen Tests Using Automated Readers. Microorganisms. 2021;9(4):827. doi:10.3390/microorganisms9040827
  • Burgos J, Garcia-Pérez JN, Lauro SG, et al. Usefulness of Sofia Pneumococcal FIA® test in comparison with BinaxNOW® Pneumococcal test in urine samples for the diagnosis of pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis. 2018;37(7):1289–1295. doi:10.1007/s10096-018-3248-0
  • Schimmel JJ, Haessler S, Imrey P, et al. Pneumococcal Urinary Antigen Testing in United States Hospitals: a Missed Opportunity for Antimicrobial Stewardship. Clin Infect Dis. 2020;71(6):1427–1434. doi:10.1093/cid/ciz983
  • Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis. 2007;44(Supplement_2):S27–S72. doi:10.1086/511159
  • Metlay J, Waterer G, Long A, et al. Diagnosis and Treatment of Adults With Community-Acquired Pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45–67. doi:10.1164/rccm.201908-1581ST
  • Falguera M, Ruiz-Gonzalez A, Schoenenberger JA, et al. Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia. Thorax. 2010;65(2):101–106. doi:10.1136/thx.2009.118588
  • Costantini E, Allara E, Patrucco F, Faggiano F, Hamid F, Balbo PE. Adherence to guidelines for hospitalized community-acquired pneumonia over time and its impact on health outcomes and mortality. Intern Emerg Med. 2016;11(7):929–940. doi:10.1007/s11739-016-1445-3
  • Uematsu H, Hashimoto H, Iwamoto T, Horiguchi H, Yasunaga H. Impact of guideline-concordant microbiological testing on outcomes of pneumonia. Int J Qual Health Care. 2014;26(1):100–107. doi:10.1093/intqhc/mzt078
  • Rosón B, Fernández-Sabé N, Carratalà J, et al. Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia. Clin Infect Dis off Publ Infect Dis Soc Am. 2004;38(2):222–226. doi:10.1086/380639
  • Bellew S, Grijalva CG, Williams DJ, et al. Pneumococcal and Legionella Urinary Antigen Tests in Community-acquired Pneumonia: prospective Evaluation of Indications for Testing. Clin Infect Dis. 2019;68(12):2026–2033. doi:10.1093/cid/ciy826
  • Hyams C, Williams OM, Williams P. Urinary antigen testing for pneumococcal pneumonia: is there evidence to make its use uncommon in clinical practice? ERJ Open Res. 2020;6(1):223–02019. doi:10.1183/23120541.00223-2019
  • West DM, McCauley LM, Sorensen JS, Jephson AR, Dean NC. Pneumococcal urinary antigen test use in diagnosis and treatment of pneumonia in seven Utah hospitals. ERJ Open Res. 2016;2(4):00011–02016. doi:10.1183/23120541.00011-2016
  • Troy LK, Wong KKH, Barnes DJ. Prevalence and Utility of Positive Pneumococcal Urinary Antigen Tests in Australian Patients with Community-Acquired Pneumonia. ISRN Infect Dis. 2012;2013:e518205. doi:10.5402/2013/518205
  • Dinh A, Duran C, Davido B, et al. Cost effectiveness of pneumococcal urinary antigen in Emergency Department: a pragmatic real-life study. Intern Emerg Med. 2018;13(1):69–73. doi:10.1007/s11739-016-1586-4
  • Andreo F, Prat C, Ruiz-Manzano J, et al. Persistence of Streptococcus pneumoniae urinary antigen excretion after pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis. 2009;28(2):197–201. doi:10.1007/s10096-008-0606-3
  • Abbott. BinaxNOW Streptococcus pneumoniae antigen card; 2021. Available from: https://www.globalpointofcare.abbott/en/product-details/binaxnow-streptococcus-pneumoniae-us.html. Accessed November 10, 2021.
  • Sinclair A, Xie X, Teltscher M, Dendukuri N. Systematic Review and Meta-Analysis of a Urine-Based Pneumococcal Antigen Test for Diagnosis of Community-Acquired Pneumonia Caused by Streptococcus pneumoniae. J Clin Microbiol. 2013;51(7):2303–2310. doi:10.1128/JCM.00137-13
  • Horita N, Miyazawa N, Kojima R, et al. Sensitivity and specificity of the Streptococcus pneumoniae urinary antigen test for unconcentrated urine from adult patients with pneumonia: a meta-analysis. Respirology. 2013;18(8):1177–1183. doi:10.1111/resp.12163
  • Molinos L, Zalacain R, Menéndez R, et al. Sensitivity, Specificity, and Positivity Predictors of the Pneumococcal Urinary Antigen Test in Community-Acquired Pneumonia. Ann Am Thorac Soc. 2015;12(10):1482–1489. doi:10.1513/AnnalsATS.201505-304OC
  • Shoji H, Domenech A, Simonetti AF, et al. The Alere BinaxNOW Pneumococcal Urinary Antigen Test: diagnostic Sensitivity for Adult Pneumococcal Pneumonia and Relationship to Specific Serotypes. J Clin Microbiol. 2018;56(2):e00787–17. doi:10.1128/JCM.00787-17
  • Ito A, Ishida T, Tachibana H, Nakanishi Y, Yamazaki A, Washio Y. Time Trend of the Sensitivity of the Pneumococcal Urinary Antigen Test for Diagnosing Pneumococcal Community-Acquired Pneumonia: an Analysis of 15-Year, Prospective Cohort Data. Infect Dis Ther. 2021;2:45. doi:10.1007/s40121-021-00508-5
  • Briones ML, Blanquer J, Ferrando D, Blasco ML, Gimeno C, Marín J. Assessment of analysis of urinary pneumococcal antigen by immunochromatography for etiologic diagnosis of community-acquired pneumonia in adults. Clin Vaccine Immunol CVI. 2006;13(10):1092–1097. doi:10.1128/CVI.00090-06
  • Sordé R, Falcó V, Lowak M, et al. Current and Potential Usefulness of Pneumococcal Urinary Antigen Detection in Hospitalized Patients With Community-Acquired Pneumonia to Guide Antimicrobial Therapy. Arch Intern Med. 2011;171(2):166–172.
  • Viasus D, Simonetti AF, Garcia-Vidal C, Niubó J, Dorca J, Carratalà J. Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia. J Antimicrob Chemother. 2017;72(2):547–5553. doi:10.1093/jac/dkw441
  • Viasus D, Vecino-Moreno M, De La Hoz JM, Carratalà J. Antibiotic stewardship in community-acquired pneumonia. Expert Rev Anti Infect Ther. 2017;15(4):351–359. doi:10.1080/14787210.2017.1274232
  • Carugati M, Franzetti F, Wiemken T, et al. De-escalation therapy among bacteraemic patients with community-acquired pneumonia. Clin Microbiol Infect. 2015;21(10):936.e11–936.e18. doi:10.1016/j.cmi.2015.06.015
  • Yamana H, Matsui H, Tagami T, Hirashima J, Fushimi K, Yasunaga H. De-escalation versus continuation of empirical antimicrobial therapy in community-acquired pneumonia. J Infect. 2016;73(4):314–325. doi:10.1016/j.jinf.2016.07.001
  • Kadri SS. A Reappraisal of Streptococcal Urinary Antigen Testing for Antibiotic Stewardship. Clin Infect Dis. 2020;71(6):1435–1437. doi:10.1093/cid/ciz989
  • Mandell L. Prospective randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia. Thorax. 2010;65(2):93–94. doi:10.1136/thx.2009.124156
  • Greenfield A, Marsh K, Siegfried J, et al. Impact of Streptococcus pneumoniae Urinary Antigen Testing in Patients with Community-acquired Pneumonia Admitted within a Large Academic Health System. Open Forum Infect Dis. 2021;1:ofab522.
  • Engel MF, Velzen M, Hoepelman AIM, Thijsen S, Oosterheert JJ. Positive urinary antigen tests for Streptococcus pneumoniae in community-acquired pneumonia: a 7-year retrospective evaluation of health care cost and treatment consequences. Eur J Clin Microbiol Infect Dis. 2013;32(4):485–492. doi:10.1007/s10096-012-1761-0
  • Marchello C, Dale AP, Thai TN, Han DS, Ebell MH. Prevalence of Atypical Pathogens in Patients With Cough and Community-Acquired Pneumonia: a Meta-Analysis. Ann Fam Med. 2016;14(6):552–566. doi:10.1370/afm.1993
  • Engel MF, van Manen L, Hoepelman AIM, Thijsen S, Oosterheert JJ. Diagnostic, therapeutic and economic consequences of a positive urinary antigen test for Legionella spp. in patients admitted with community-acquired pneumonia: a 7-year retrospective evaluation. J Clin Pathol. 2013;66(9):797–802. doi:10.1136/jclinpath-2012-201209
  • Yu VL, Stout JE. Rapid Diagnostic Testing for Community-Acquired Pneumonia: can Innovative Technology for Clinical Microbiology Be Exploited? Chest. 2009;136(6):1618–1621. doi:10.1378/chest.09-0939
  • Walser SM, Gerstner DG, Brenner B, Höller C, Liebl B, Herr CEW. Assessing the environmental health relevance of cooling towers – a systematic review of legionellosis outbreaks. Int J Hyg Environ Health. 2014;217(2–3):145–154. doi:10.1016/j.ijheh.2013.08.002
  • Sopena N, Sabrià M, Pedro-Botet ML, et al. Factors Related to Persistence of Legionella Urinary Antigen Excretion in Patients with Legionnaires’ Disease. Eur J Clin Microbiol Infect Dis. 2002;21(12):845–848. doi:10.1007/s10096-002-0839-5
  • Beauté J. Legionnaires’ disease in Europe, 2011 to 2015. Eurosurveillance. 2017;22(27):30566. doi:10.2807/1560-7917.ES.2017.22.27.30566
  • Wong AYW, Johnsson ATA, Iversen A, Athlin S, Özenci V. Evaluation of Four Lateral Flow Assays for the Detection of Legionella Urinary Antigen. Microorganisms. 2021;9(3):493. doi:10.3390/microorganisms9030493
  • Mercante JW, Winchell JM. Current and emerging Legionella diagnostics for laboratory and outbreak investigations. Clin Microbiol Rev. 2015;28(1):95–133. doi:10.1128/CMR.00029-14
  • Yu VL, Plouffe JF, Pastoris MC, et al. Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey. J Infect Dis. 2002;186(1):127–128. doi:10.1086/341087
  • Kohler RB, Winn WC, Wheat LJ. Onset and duration of urinary antigen excretion in Legionnaires disease. J Clin Microbiol. 1984;20(4):605–607.
  • Yzerman EPF, den Boer JW, Lettinga KD, Schellekens J, Dankert J, Peeters M. Sensitivity of three urinary antigen tests associated with clinical severity in a large outbreak of Legionnaires’ disease in The Netherlands. J Clin Microbiol. 2002;40(9):3232–3236. doi:10.1128/JCM.40.9.3232-3236.2002
  • Helbig JH, Uldum SA, Bernander S, et al. Clinical Utility of Urinary Antigen Detection for Diagnosis of Community-Acquired, Travel-Associated, and Nosocomial Legionnaires’ Disease. J Clin Microbiol. 2003;41(2):838–840. doi:10.1128/JCM.41.2.838-840.2003
  • Allgaier J, Lagu T, Haessler S, et al. Risk Factors, Management, and Outcomes of Legionella Pneumonia in a Large, Nationally Representative Sample. Chest. 2021;159(5):1782–1792. doi:10.1016/j.chest.2020.12.013
  • Waterer GW, Baselski VS, Wunderink RG. Legionella and community-acquired pneumonia: a review of current diagnostic tests from a clinician’s viewpoint. Am J Med. 2001;110(1):41–48. doi:10.1016/S0002-9343(00)00624-0
  • Henry C, Boethel C, Copeland LA, Ghamande S, Arroliga AC, White HD. Clinical Utility of Testing for Legionella Pneumonia in Central Texas. Ann Am Thorac Soc. 2017;14(1):65–69. doi:10.1513/AnnalsATS.201606-501BC
  • Ito A, Yamamoto Y, Ishii Y, et al. Evaluation of a novel urinary antigen test kit for diagnosing Legionella pneumonia. Int J Infect Dis. 2021;103:42–47. doi:10.1016/j.ijid.2020.10.106
  • Shimada T, Noguchi Y, Jackson JL, et al. Systematic Review and Meta-analysis: urinary Antigen Tests for Legionellosis. Chest. 2009;136(6):1576–1585. doi:10.1378/chest.08-2602
  • Roed T, Schønheyder HC, Nielsen H. Predictors of positive or negative legionella urinary antigen test in community-acquired pneumonia. Infect Dis Lond Engl. 2015;47(7):484–490. doi:10.3109/23744235.2015.1021830
  • Fiumefreddo R, Zaborsky R, Haeuptle J, et al. Clinical predictors for Legionella in patients presenting with community-acquired pneumonia to the emergency department. BMC Pulm Med. 2009;9(1):4. doi:10.1186/1471-2466-9-4
  • Miyashita N, Horita N, Higa F, et al. Validation of a diagnostic score model for the prediction of Legionella pneumophila pneumonia. J Infect Chemother. 2019;25(6):407–412. doi:10.1016/j.jiac.2019.03.009
  • Ito A, Ishida T, Washio Y, Yamazaki A, Tachibana H. Legionella pneumonia due to non-Legionella pneumophila serogroup 1: usefulness of the six-point scoring system. BMC Pulm Med. 2017;17(1):211. doi:10.1186/s12890-017-0559-3
  • Levcovich A, Lazarovitch T, Moran-Gilad J, et al. Complex clinical and microbiological effects on Legionnaires’ disease outcome; A retrospective cohort study. BMC Infect Dis. 2016;16:75. doi:10.1186/s12879-016-1374-9
  • Lettinga KD, Verbon A, Weverling GJ, et al. Legionnaires’ disease at a Dutch flower show: prognostic factors and impact of therapy. Emerg Infect Dis. 2002;8(12):1448–1454. doi:10.3201/eid0812.020035
  • Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(Suppl 3):iii1–iii55. doi:10.1136/thx.2009.121434
  • Ewig S, Höffken G, Kern WV, et al. Management of Adult Community-acquired Pneumonia and Prevention - Update 2016. Pneumol Stuttg Ger. 2016;70(3):151–200. doi:10.1055/s-0042-101873
  • Menéndez R, Torres A, Aspa J, et al. Community acquired pneumonia: new guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR). Arch Bronconeumol. 2010;46(10):543–558. doi:10.1016/j.arbres.2010.06.014
  • van der Eerden MM. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study. Thorax. 2005;60(8):672–678. doi:10.1136/thx.2004.030411
  • Peci A, Winter AL, Gubbay JB. Evaluation and Comparison of Multiple Test Methods, Including Real-time PCR, for Legionella Detection in Clinical Specimens. Front Public Health. 2016;4:175. doi:10.3389/fpubh.2016.00175
  • Keše D, Obreza A, Rojko T, Kišek TC. Legionella pneumophila-Epidemiology and Characterization of Clinical Isolates, Slovenia, 2006–2020. Diagn Basel Switz. 2021;11(7):1201. doi:10.3390/diagnostics11071201
  • Dionne M, Hatchette T, Forward K. Clinical utility of a Legionella pneumophila urinary antigen test in a large university teaching hospital. Can J Infect Dis J Can Mal Infect. 2003;14(2):85–88. doi:10.1155/2003/642159
  • Yu VL. A clinical solution to antimicrobial resistance in community-acquired pneumonia: narrowing the spectrum of antimicrobial therapy: comment on “Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy.”. Arch Intern Med. 2011;171(2):172–173. doi:10.1001/archinternmed.2010.474